Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
about
Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriersIsoxyl aerosols for tuberculosis treatment: preparation and characterization of particlesComparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical modelEffects of microparticle size and Fc density on macrophage phagocytosisCurrent applications and future prospects of nanomaterials in tumor therapyIn vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapiesCurrent advances in research and clinical applications of PLGA-based nanotechnology.Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment.Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheresMacrophage fusion leading to foreign body giant cell formation persists under phagocytic stimulation by microspheres in vitro and in vivo in mouse models.Characterization of topographical effects on macrophage behavior in a foreign body response modelLiposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in AtherosclerosisEffect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.Exploiting viral properties for the rational design of modern vaccines.Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats.Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.Delivery strategies for antiparasitics.Tuberculosis chemotherapy: current drug delivery approaches.Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells.Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritisNanoparticle-loaded macrophage-mediated photothermal therapy: potential for glioma treatmentGamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensNanotechnology and the treatment of HIV infection.Antitubercular inhaled therapy: opportunities, progress and challenges.Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.Improving selective targeting to macrophage subpopulations through modifying liposomes with arginine based materials.Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.Recent advances in delivery systems for anti-HIV1 therapy.Swellable microparticles as carriers for sustained pulmonary drug deliveryExploring the effect of silver nanoparticle size and medium composition on uptake into pulmonary epithelial 16HBE14o-cellsEvaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus.TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITYPhagocytosis dynamics depends on target shape.Peritoneal macrophage uptake, pharmacokinetics and biodistribution of macrophage-targeted PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarriers for improving HIV drug delivery.
P2860
Q28384922-FC9002F3-C9A4-42E9-B54D-C6C3E5FB9239Q28396917-5813C886-A741-41AA-BC75-272858FC7223Q28484470-892D62B4-2BA5-458F-9751-239EB36E1512Q28486443-59F6AEDA-DD2E-4C9B-8579-040B639E7067Q29248618-64D1A584-2A18-471D-9EB4-0025954D19D8Q30427531-FACB7882-2AE1-4A01-AA56-277415FEA1CDQ30482916-B5A28664-7FE1-4157-A5E1-A106BE9A81BBQ33219747-285174AC-283A-4EA5-9FD9-F6844AA7338DQ33617249-EADA5474-DCB4-4A87-A897-7FE2530E9A57Q33679249-11331203-357C-4E06-B459-2155A9F07865Q33721768-1746EF87-1B98-4836-B8CB-E839EC587E5BQ33797873-75135E59-48B0-44F5-8B05-F2934D537FD9Q33856678-FD16EC0F-E5E1-4822-A02F-E00FAEEC3B87Q33906751-A6F86688-7DC4-44ED-B56E-12181305C795Q33949943-A6455A1C-233C-4389-96E1-87D57BB54163Q33960181-EDA6BEB1-B813-4425-AEC8-56E5745D0501Q34746490-79A524E6-B7D3-422D-B995-4DFF5A20CDEAQ34999159-BAA361D0-18A2-440E-9C32-BDB28F536E85Q35034311-5907AAB8-9185-4EE9-A465-C4AFE70A4CC9Q35056056-7589D651-F3F4-4F8B-A151-27356702C103Q35069271-31715AA2-D000-480C-A707-FB448D9A938EQ35193439-D2D3CA24-D05D-4AD8-94DB-D12CD436CDECQ35249558-6113EE3E-F1D3-4887-966F-67D562314171Q35553944-8D0FAEC9-3D97-41A6-95A7-C3D07F0A0BC7Q35582867-59DF04F2-CAE2-441B-BDDD-97010D2AA063Q35758859-A263BABD-EBF8-42C3-B7A2-9C06425E46A8Q35812875-ED60ABB5-67E1-436E-B4D1-858513190D61Q35943647-5DC47006-F1BA-40F7-9C60-C9B5C32A7679Q36068001-444C35F3-A106-438A-A6EB-E759F326195FQ36087004-D7E748C4-5C5B-4605-83EB-383CC96BDA20Q36191455-CFB2F873-FD59-491A-84F1-4D6C1127F010Q36349667-49BFF2E7-E730-4A20-8A86-0BF7324CA822Q36517179-8FE08D23-8A25-4F72-B9C5-7946B19F7FE1Q36761854-68DCC986-D05C-4BC4-A893-83AFFD9EA5A5Q36846462-33E798DA-7A64-4F0B-8D82-7739EFF15BE3Q37060011-82EA3DC4-56D3-4FB9-A2E8-3A0627F4FF14Q37120632-DEE317BB-8AE2-4BBE-A287-2DC8C5B22D99Q37137646-E2587D58-75F0-4A12-89FB-FAE4497A445AQ37145658-C3D1E66C-139F-44C3-88B7-800DAEF223B5Q37192494-35F923A9-B3CF-4284-BDEE-C095CC1490FC
P2860
Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@ast
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@en
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@nl
type
label
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@ast
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@en
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@nl
prefLabel
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@ast
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@en
Targeting to macrophages: role ...... e phagocytosis by macrophages.
@nl
P2093
P921
P1476
Targeting to macrophages: role ...... he phagocytosis by macrophages
@en
P2093
Fakhrul Ahsan
Isabel P Rivas
Mansoor A Khan
P356
10.1016/S0168-3659(01)00549-1
P407
P577
2002-02-01T00:00:00Z